Carlton South Vic 3053, Australia
Go to Investors Hub
info@radiopharmtheranostics.com

Pivalate achieves positive Phase 2 data in brain mets trial

Leave a Reply

Your email address will not be published.Required fields are marked *

More Announcements & Updates

RAD Share Facility Agreement of up to A$12.5m addendum
Top 20 Shareholders
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart (RV-01)
RAD Reports Positive Preclinical Lu177-B7H3-mAb Data
Categories
Announcements
Announcements
Annual Reports
Annual Reports
Presentations
Presentations
News
News
Recent News
Analyst ReportsAnnouncementsAnnual ReportsInvestor PresentationsRAD ArticlesUpdates
Tags
Tags
Appendix 2A (1) Appendix 3B (1) Change of Director's Interest Notice (1) Cleansing Notice (1) PDF (23) Periodic Reports (24) Price Sensitive (84) Progress Report (2) Video (3) With Summary (2) With Video (4)
Archives
Archives
RSS RSS
Close
Search

Hit enter to search or ESC to close

cookie By using this website, you agree to our cookie policy. Close